Life 4 Liam
Donate
All treatments FDA-approved

Aqneursa (levacetylleucine)

A stand-alone oral medicine that helps lysosomes and brain cells work better.

Still image of Aqneursa (levacetylleucine)
A still of the idea behind Aqneursa (levacetylleucine). The motion below is a simple animation, not a replacement for this picture.

How it works

Aqneursa is levacetylleucine, a modified amino acid. It helps stressed cells improve energy use and lysosomal function, which can ease neurological symptoms such as balance, speech, and fine motor control.

Unlike Miplyffa, it is approved as a stand-alone therapy for people weighing at least 15 kilograms.

Who it is for

Adults and children who weigh at least 15 kg.

What it does not do

It does not clear all stored cholesterol or replace the missing NPC1 protein.

Step by step

What this treatment does

Four short pictures of the idea. Play through, or tap a step. This is a teaching picture, not a medical simulation.

Step 1 of 4 · The problem

Lysosomes and brain cells are under stress

Cholesterol traffic is jammed. Energy use and cell cleanup suffer, which shows up as balance, speech, and motor problems.

Official information

Educational only. Ask an NPC specialist what is right for a specific child or adult. Official sites and FDA pages are the source of prescribing information.